Supplementary protection certificate for medicinal products (recast)

Date: 28.02.2024 · Reference: A9-0022/2024

paediatrics market approval competitiveness intellectual property medicinal product pharmaceutical legislation European patent innovation public health codification of EU law medical research marketing standard
Overall Result: 526 For
526 For
23 Against
70 Abstention
248 Did not vote
Report Summary
Source: AI Summary with Mistral
  • Revised supplementary protection certificate for medicinal products.
  • Emphasis on transparency and procedure acceleration.
  • Involvement of national patent offices in centralized processes.
Filter by Country
← Go back